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INTRODUCTION
Drug hypersensitivity reactions are adverse reactions to 
drugs that were administered at a dose that is tolerated by 
normal subjects, but produce symptoms that, from a clinical 
perspective, resemble an allergy. The revised nomenclature 
for allergies classifies hypersensitivity reactions to drugs as 
either allergic or non allergic. Drug allergies occur when 
immunologic mechanisms have been demonstrated.1 
Allergic reactions caused by antifungal drugs are not 
frequently reported in clinical practice. Until now, the 
pathogenesis of hypersensitivity reactions to ketoconazole 
and other azole derivatives is unknown.2 Herein, we report 
an immediate reaction to ketoconazole and review the 
usefulness of a drug provocation test for diagnosis. 
CASE DESCRIPTION
A  40-year-old  man  began  oral  treatment  with 
ketoconazole at a dosage of 400 mg per day for prophylaxis 
of candidiasis. Forty minutes after administration of the first 
dose, he developed angioedema of the face in addition to 
generalized urticaria. The symptoms were quickly reduced 
by administration of parenteral steroids and anti-histaminics. 
Notably, the patient had no personal or familiar history of 
allergies. In addition, while the patient had never taken this 
drug before, he had taken fluconazole approximately one 
year ago without noticing any adverse reactions. The patient 
denied the use of any other medicine at the time of taking 
ketoconazole and indicated that he did not have any previous 
episodes of urticaria or angioedema.
Skin prick tests with ketoconazole at a concentration of 
1, 10, 20, and 40 mg/ml were all negative. A single blind 
placebo controlled oral challenge test with commercial 
ketoconazole (200 mg) was performed, showing an 
immediate response characterized by urticariform exanthema 
and angioedema within 50 minutes from ingestion 
of the drug. Parenteral hydrocortisone (200 mg) and 
diphenidramine (50 mg) were subsequently administered 
after which the symptoms were abated. In addition, no late 
response to the drug was observed.
DISCUSSION
Drug hypersensitivity can affect as many as 12 % 
of the general population, whereby non-steroid anti-
inflammatory drugs and antibiotics are the most frequently 
implicated drugs.3 This case, which involves an immediate 
hypersensitivity to ketoconazole, is extremely rare and in 
fact, this is the first case study suggestive of an allergic 
reaction to ketoconazole to be reported in Brazil. 
Immediate drug hypersensitivity occurs within the first 
hour after drug administration and is probably mediated by 
an IgE-dependent mechanism. The reaction, from a clinical 
perspective, is characterized by urticaria, angioedema, 
rhinitis, bronchospasm and anaphylactic shock. This patient 
presented an immediate reaction that was characterized by a 
rapid onset of the aforementioned symptoms (urticaria and 
angioedema).
The diagnosis of an immediate hypersensitivity reaction 
should include both in vitro and in vivo tests (Figure 1). 
Figure 1 - Flow chart for the evaluation of type 1 hypersensitivity drug 
reactions.
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However, the required serum specific IgE assays are only 
available for a few drugs, not including the azole derivatives. 
Additional in vitro tests, such as the flow cytometric basophil 
activation test, have not yet been validated, and their 
sensitivity is not 100 %.4 
Skin tests are the most readily available method for 
physicians to test for the presence of an allergy. Currently, 
skin prick tests to determine if there is an allergy to a specific 
drug can only be validated for beta-lactam antibiotics and 
insulin. Due to their greater sensitivity, skin tests cannot be 
replaced by in vitro tests. The skin prick test administered 
in this case study was performed as described previously for 
ketoconazole.5 However, unlike the results from this previous 
report, our results were negative. This was probably due to 
the lack of a standardized procedure for administering the 
prick test for ketoconazole. 
The drug provocation test (DPT) is the gold standard for 
the identification of an eliciting drug when allergologic tests 
results are negative, not available, or cannot be validated. As 
recommended by the European Network for Drug Allergy, 
the commercial preparation of the drug was administered 
in the same way as it was administered when the reaction 
occurred. The starting dose was 10 % of the therapeutic 
dose, with an increasing dose of 20 % of the therapeutic 
dose to be administered 20 minutes after the starting dose.6 
However, the first symptoms appeared prior to the second 
dose, whereby the test was stopped.
Despite its potential risk, the DPT was useful in this 
particular case since ketoconazole was not a frequent cause 
for a reaction. In this case, avoiding ketoconazole will 
prevent other severe reactions. Since cross-reactivity between 
azole derivatives is possible, a DPT should be performed 
before the use of another drug from this group. 
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